Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Francisco

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Cancer|December 9, 2022
Severe, life-threatening, and fatal chronic health conditions after allogeneic blood or marrow transplantation in childhoodAnna Sällfors Holmqvist, Yanjun Chen, Lindsey Hageman, et al.
Leukemia|February 20, 2024
Late morbidity and mortality after autologous blood or marrow transplantation for lymphoma in children, adolescents and young adults-a BMTSS reportAnna Sällfors Holmqvist, Qingrui Meng, Chen Dai, et al.
Toxicon: X|July 3, 2020
Isolation and structural characterization of bioactive compound from <i>Aristolochia sprucei</i> aqueous extract with anti-myotoxic activityIsela I González Rodríguez, Aleff F Francisco, Leandro S Moreira-Dill, et al.
Plos Neglected Tropical Diseases|May 24, 2019
A single dose of antibody-drug conjugate cures a stage 1 model of African trypanosomiasisPaula MacGregor, Andrea L Gonzalez-Munoz, Fatoumatta Jobe, et al.
Nature Communications|August 29, 2022
Invariant surface glycoprotein 65 of Trypanosoma brucei is a complement C3 receptorOlivia J S Macleod, Alexander D Cook, Helena Webb, et al.
Journal of Medicinal Chemistry|September 16, 2022
Nitroimidazopyrazinones with Oral Activity against Tuberculosis and Chagas Disease in Mouse Models of InfectionChee Wei Ang, Brendon M Lee, Colin J Jackson, et al.
International Journal of Biological Macromolecules|July 1, 2021
Gallic acid anti-myotoxic activity and mechanism of action, a snake venom phospholipase A<sub>2</sub> toxin inhibitor, isolated from the medicinal plant Anacardium humileTássia R Costa, Aleff F Francisco, Fábio F Cardoso, et al.
Biochimie|May 19, 2025
Structural and kinetic profiling of Leishmania braziliensis trypanothione reductase: A molecular model for the development of targeted therapiesAna F Gómez Garay, Jorge J Alfonso, Aleff F Francisco, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 16, 2023
Cytokine storm in individuals with severe COVID-19 decreases endothelial cell antioxidant defense via downregulation of the Nrf2 transcriptional factorDaniel Rodrigues, Mirele R Machado, Juliano V Alves, et al.
Biomed Research International|August 1, 2022
Anti-Metalloprotease P-I Single-Domain Antibodies: Tools for Next-Generation Snakebite AntivenomsMarcela C S Silva, Soraya S Pereira, Marilia P Gouveia, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Cancer|December 9, 2022
Severe, life-threatening, and fatal chronic health conditions after allogeneic blood or marrow transplantation in childhoodAnna Sällfors Holmqvist, Yanjun Chen, Lindsey Hageman, et al.
Leukemia|February 20, 2024
Late morbidity and mortality after autologous blood or marrow transplantation for lymphoma in children, adolescents and young adults-a BMTSS reportAnna Sällfors Holmqvist, Qingrui Meng, Chen Dai, et al.
Toxicon: X|July 3, 2020
Isolation and structural characterization of bioactive compound from <i>Aristolochia sprucei</i> aqueous extract with anti-myotoxic activityIsela I González Rodríguez, Aleff F Francisco, Leandro S Moreira-Dill, et al.
Plos Neglected Tropical Diseases|May 24, 2019
A single dose of antibody-drug conjugate cures a stage 1 model of African trypanosomiasisPaula MacGregor, Andrea L Gonzalez-Munoz, Fatoumatta Jobe, et al.
Nature Communications|August 29, 2022
Invariant surface glycoprotein 65 of Trypanosoma brucei is a complement C3 receptorOlivia J S Macleod, Alexander D Cook, Helena Webb, et al.
Journal of Medicinal Chemistry|September 16, 2022
Nitroimidazopyrazinones with Oral Activity against Tuberculosis and Chagas Disease in Mouse Models of InfectionChee Wei Ang, Brendon M Lee, Colin J Jackson, et al.
International Journal of Biological Macromolecules|July 1, 2021
Gallic acid anti-myotoxic activity and mechanism of action, a snake venom phospholipase A<sub>2</sub> toxin inhibitor, isolated from the medicinal plant Anacardium humileTássia R Costa, Aleff F Francisco, Fábio F Cardoso, et al.
Biochimie|May 19, 2025
Structural and kinetic profiling of Leishmania braziliensis trypanothione reductase: A molecular model for the development of targeted therapiesAna F Gómez Garay, Jorge J Alfonso, Aleff F Francisco, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 16, 2023
Cytokine storm in individuals with severe COVID-19 decreases endothelial cell antioxidant defense via downregulation of the Nrf2 transcriptional factorDaniel Rodrigues, Mirele R Machado, Juliano V Alves, et al.
Biomed Research International|August 1, 2022
Anti-Metalloprotease P-I Single-Domain Antibodies: Tools for Next-Generation Snakebite AntivenomsMarcela C S Silva, Soraya S Pereira, Marilia P Gouveia, et al.
Pageof 5